In The News: Department of Psychology
Thousands suffering from epilepsy have been given new hope as a new breakthrough brings scientists one step closer to being able to "turn off" epileptic seizures.
Thousands suffering from epilepsy have been given new hope as a new breakthrough brings scientists one step closer to being able to "turn off" epileptic seizures.
Science is a step towards developing targeted drug therapies that can reduce seizures, sleep disturbances and related symptoms common in people with intellectual disabilities.
Science is a step towards developing targeted drug therapies that can reduce seizures, sleep disturbances and related symptoms common in people with intellectual disabilities.
In this episode we’ll be discussing if cannabis can really be considered as a psychedelic and how cannabis really compares to psychedelics.
Navigating the experience of being both AAPI and LGBTQ+ can be a fraught experience—but when you've found your community, it can be a joyful one, too.
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
A recent study has given a new ray of hope by showing that science is getting one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
A recent study has given a new ray of hope by showing that science is getting one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.
Science is one step closer to developing targeted drug therapies that may reduce seizures, sleep disorders, and related symptoms common in people with intellectual disabilities.